125 related articles for article (PubMed ID: 1466298)
1. Bradykinin antagonists do not require a D-aromatic amino acid residue at position 7.
Vavrek RJ; Gera L; Stewart JM
Agents Actions Suppl; 1992; 38 ( Pt 1)():572-81. PubMed ID: 1466298
[TBL] [Abstract][Full Text] [Related]
2. Pseudopeptide analogs of bradykinin and bradykinin antagonists.
Vavrek RJ; Gera L; Stewart JM
Agents Actions Suppl; 1992; 38 ( Pt 1)():565-71. PubMed ID: 1466297
[TBL] [Abstract][Full Text] [Related]
3. A new class of bradykinin antagonists containing indanylglycine.
Gera L; Stewart JM
Immunopharmacology; 1996 Jun; 33(1-3):174-7. PubMed ID: 8856143
[No Abstract] [Full Text] [Related]
4. Bradykinin antagonists: synthesis and in vitro activity of bissuccinimidoalkane peptide dimers.
Cheronis JC; Whalley ET; Blodgett JK
Agents Actions Suppl; 1992; 38 ( Pt 1)():551-8. PubMed ID: 1466296
[TBL] [Abstract][Full Text] [Related]
5. Bradykinin competitive antagonists for classical kinin systems.
Stewart JM; Vavrek RJ
Adv Exp Med Biol; 1986; 198 Pt A():537-42. PubMed ID: 3812091
[TBL] [Abstract][Full Text] [Related]
6. Highly selective bradykinin agonists and antagonists with replacement of proline residues by N-methyl-D- and L-phenylalanine.
Reissmann S; Schwuchow C; Seyfarth L; Pineda De Castro LF; Liebmann C; Paegelow I; Werner H; Stewart JM
J Med Chem; 1996 Feb; 39(4):929-36. PubMed ID: 8632416
[TBL] [Abstract][Full Text] [Related]
7. New and highly potent bradykinin antagonists.
Knolle J; Breipohl G; Henke S; Wirth K; Schölkens B
Agents Actions Suppl; 1992; 38 ( Pt 1)():559-64. PubMed ID: 1334632
[No Abstract] [Full Text] [Related]
8. Competitive antagonists of bradykinin.
Vavrek RJ; Stewart JM
Peptides; 1985; 6(2):161-4. PubMed ID: 4034408
[TBL] [Abstract][Full Text] [Related]
9. Bradykinin analogs containing alpha-aminoisobutyric acid (Aib).
Vavrek RJ; Stewart JM
Peptides; 1980; 1(3):231-5. PubMed ID: 7232227
[TBL] [Abstract][Full Text] [Related]
10. A new generation of bradykinin antagonists.
Stewart JM; Gera L; Hanson W; Zuzack JS; Burkard M; McCullough R; Whalley ET
Immunopharmacology; 1996 Jun; 33(1-3):51-60. PubMed ID: 8856115
[TBL] [Abstract][Full Text] [Related]
11. Smooth muscle selectivity in bradykinin analogs with multiple D-amino acid substitutions.
Vavrek RJ; Stewart JM
Adv Exp Med Biol; 1986; 198 Pt A():543-7. PubMed ID: 3812092
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the antagonistic actions of HOE 140 and other novel bradykinin analogues on the guinea-pig ileum.
Griesbacher T; Lembeck F
Eur J Pharmacol; 1992 Feb; 211(3):393-8. PubMed ID: 1618275
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological activities of new side chain and backbone cyclic bradykinin analogues.
Schumann C; Seyfarth L; Greiner G; Paegelow I; Reissmann S
J Pept Res; 2002 Aug; 60(2):128-40. PubMed ID: 12102726
[TBL] [Abstract][Full Text] [Related]
14. A new class of bradykinin antagonists: synthesis and in vitro activity of bissuccinimidoalkane peptide dimers.
Cheronis JC; Whalley ET; Nguyen KT; Eubanks SR; Allen LG; Duggan MJ; Loy SD; Bonham KA; Blodgett JK
J Med Chem; 1992 May; 35(9):1563-72. PubMed ID: 1578482
[TBL] [Abstract][Full Text] [Related]
15. Bradykinin receptor antagonists containing N-substituted amino acids: in vitro and in vivo B(2) and B(1) receptor antagonist activity.
Goodfellow VS; Marathe MV; Kuhlman KG; Fitzpatrick TD; Cuadrado D; Hanson W; Zuzack JS; Ross SE; Wieczorek M; Burkard M; Whalley ET
J Med Chem; 1996 Mar; 39(7):1472-84. PubMed ID: 8691478
[TBL] [Abstract][Full Text] [Related]
16. New bradykinin B(2) receptor antagonists - influence of C-terminal segment modifications on their pharmacological properties.
Sleszyńska M; Kwiatkowska A; Sobolewski D; Wierzba TH; Katarzyńska J; Zabrocki J; Borovickova L; Slaninová J; Prahl A
Acta Biochim Pol; 2009; 56(4):641-8. PubMed ID: 19997652
[TBL] [Abstract][Full Text] [Related]
17. Potent photoaffinity labelled and iodinated antagonists of bradykinin.
Schumann C; Steinmetzer T; Gothe R; Hoppe A; Paegelow I; Liebmann C; Fabry M; Brandenburg D; Reissmann S
Biol Chem Hoppe Seyler; 1995 Jan; 376(1):33-8. PubMed ID: 7612186
[TBL] [Abstract][Full Text] [Related]
18. New cyclic bradykinin antagonists containing disulfide and lactam bridges at the N-terminal sequence.
Seyfarth L; Pineda de Castro LF; Liepina I; Paegelow I; Liebmann C; Reissmann S
Int J Pept Protein Res; 1995 Aug; 46(2):155-65. PubMed ID: 8567170
[TBL] [Abstract][Full Text] [Related]
19. Development of bradykinin antagonists: structure-activity relationships for new categories of antagonist sequences.
Vavrek RJ; Stewart JM
Adv Exp Med Biol; 1989; 247B():395-400. PubMed ID: 2610083
[No Abstract] [Full Text] [Related]
20. Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies.
Hock FJ; Wirth K; Albus U; Linz W; Gerhards HJ; Wiemer G; Henke S; Breipohl G; König W; Knolle J
Br J Pharmacol; 1991 Mar; 102(3):769-73. PubMed ID: 1364851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
